Medical News

Comparison of Biologics in the Treatment of Chronic Rhinosinusitis with Nasal Polyps

7. 9. 2022 Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation

The authors of a meta-analysis of nine randomized controlled trials comparing dupilumab, omalizumab, and mepolizumab in patients with chronic rhinosinusitis and nasal polyps attempted to identify the most advantageous of the available biologics for this indication based on the ratio of benefits to risks.

Current Challenges in Diagnosing Progressive Fibrotic Interstitial Lung Diseases

A subset of patients with interstitial lung diseases exhibits a progressive fibrotic phenotype associated with a deterioration in quality of life and increased mortality. Early diagnosis and adequate…

7. 9. 2022 Source: Progressive Interstitial Pulmonary Processes

Limosilactobacillus reuteri as a supplement for improving periodontal health when oral hygiene is compromised

The effect of probiotics on periodontal health was investigated in a German study conducted on a group of sailors during their service at sea. Among the most common causes of the overgrowth of…

6. 9. 2022 Source: GI, colic and microbiome

Probiotics as a Helper in the Fight Against Pregnancy Gingivitis

Gingivitis is a common problem during pregnancy. In addition to quality oral hygiene, regular consumption of probiotic preparations containing certain strains of Limosilactobacillus reuteri can also…

2. 9. 2022 Source: GI, colic and microbiome

chronické obstrukční plicní nemoci_dýchání

Current Findings on Fixed Combination Aclidinium/Formoterol in COPD Therapy

The fixed inhalation combination of aclidinium/formoterol represents a combination of a long-acting anticholinergic (LAMA) and a long-acting β₂-mimetic (LABA) used for maintenance treatment of…

30. 8. 2022 Source: Treatment of Asthma and COPD

Overview of the Efficacy of the Fixed Combination Aclidinium-Bromide/Formoterol-Fumarate in the Maintenance Treatment of COPD

Fixed combination inhalation medications have become the cornerstone of pharmacotherapy for moderate to severe chronic obstructive pulmonary disease (COPD). American authors have published an…

30. 8. 2022 Source: Treatment of Asthma and COPD

New Solution for Moderate Incontinence –⁠ Discreet Pull-Up Diaper Pants

The range of products for people with incontinence is constantly expanding –⁠ recent additions include pull-up diaper pants labeled Seni Active Basic and Seni Active Classic.

30. 8. 2022 Source: Incontinence

How to Maintain Hygiene for Incontinent Patients Without Using Water?

Urinary incontinence brings numerous health risks. Due to frequent continuous contact of aggressive urine with the skin, a significant number of patients develop skin complications such as eczema,…

29. 8. 2022 Source: Incontinence

Current Therapy Options for Interstitial Lung Diseases

Interstitial lung diseases (ILDs) represent a heterogeneous group of disorders characterized by inflammatory or fibrotic changes in the lung parenchyma. Simply put, they can be divided into…

29. 8. 2022 Source: Progressive Interstitial Pulmonary Processes

First mRNA Treatment for Glycogen Storage Disease Already in Testing Phase

Glycogen storage disease type Ia, also known as von Gierke disease, is a serious inherited disorder with an autosomal recessive inheritance pattern, caused by a deficiency of the enzyme…

25. 8. 2022 Source: medScope.pro

CASE STUDIES: Treatment Options for Wounds in Cancer Patients

Wounds arising due to generalized cancerous diseases or their treatments require specific procedures to support healing. To illustrate, we select three brief case studies from our practice, accompanied...

22. 8. 2022 Source: Wound Healing

Risk of Venous Thromboembolism and CV Events during Targeted Treatment of Nonspecific Bowel Inflammations

Authors of a freshly published study based on real-world data from the USA investigated whether there are differences in the risk of venous thromboembolism (VTE) and major cardiovascular (CV) events…

22. 8. 2022 Source: Intestinal Inflammations

Comparison of the Efficacy of Tofacitinib and Vedolizumab in the Treatment of Ulcerative Colitis After Anti-TNF Therapy Failure

Therapeutic options for ulcerative colitis resistant to anti-TNF-α antibody treatment are available, but there were no studies comparing the selective immunosuppressants tofacitinib and vedolizumab…

21. 8. 2022 Source: Intestinal Inflammations

Bone density in hemophiliacs −⁠ known and less-known risk factors

Osteopenia or osteoporosis are known comorbidities of hemophilia and concern many of these patients. What all contributes to their development?

20. 8. 2022 Source: Hemophilia

Turoctocog Alfa in Tertiary Prophylaxis of Hemophilia A or Is It Always About Bleeding? Case Studies

This case report from our own practice concerns our experience with the treatment of hemophilia A with turoctocog alfa. The intention is, among other things, to compare different outcomes in our two…

19. 8. 2022 Source: Hemophilia with Movement

1 … 44 45 46 47 48 … 111

Back Filter by speciality

Remove filters